Highlights
KLSE: KOTRA (0002)       KOTRA INDUSTRIES BHD MAIN : Health Care
Last Price Today's Change   Day's Range   Trading Volume
3.37   0.00 (0.00%)  3.32 - 3.40  66,000
Trade this stock and receive a FREE I3investor T-shirt after 5 trades. Find out more.

Overview

Market Cap: 499 Million
NOSH: 148 Million
Avg Volume (4 weeks):54,795
4 Weeks Range:3.04 - 3.70
4 Weeks Price Volatility (%):
50.00%
52 Weeks Range:2.25 - 3.70
52 Weeks Price Volatility (%):
77.24%
Average Price Target: 0.61
Price Target Upside/Downside: -2.76
Stamp duty exempted for year 2022

Financial Highlight

Latest Quarter | Ann. Date 30-Sep-2021 [#1]  |  26-Nov-2021
Next QR | Est. Ann. Date: 31-Dec-2021  |  19-Feb-2022
T4Q P/E | EY: 13.54  |  7.39%
T4Q DY | Payout %: 0.01%  |  0.08%
T4Q NAPS | P/NAPS: 1.5  |  2.25
T4Q NP Margin | ROE: 20.92%  |  16.59%

Headlines

Date Subject
02-Sep-2021 上升股:康大工业 阻力RM3.90

Business Background

Kotra Industries Bhd is an investment holding company. Along with its subsidiaries, the company is engaged in research and development, manufacturing and trading of pharmaceutical and healthcare products. Its product range includes nutraceutical and pharmaceutical products. It offers tablets, capsules, creams, and ointments under the brand name Appeton, Axcel, and Vaxcel. It operates in Malaysia.
Analyze this stock with MQ Trader system

  3 people like this.
 
1lotman any good news from today AGM?
20/11/2020 6:02 PM
NPRA1985 UAE says Sinopharm vaccine has 86% efficacy against COVID-19

DUBAI (Reuters) - An experimental coronavirus vaccine developed by China’s Sinopharm has 86% efficacy against the virus, the United Arab Emirates health ministry said on Wednesday, citing an interim analysis of a human trial underway there.

The Gulf Arab state in July started Phase 3 clinical trials of the vaccine, developed by Beijing Institute of Biological Product, a unit of Sinopharm’s China National Biotec Group (CNBG). In September, the UAE approved its emergency use for certain groups.

The analysis also shows “99% seroconversion rate of neutralizing antibody and 100% effectiveness in preventing moderate and severe cases of the disease”, the ministry said in a statement carried by the state news agency.

“The analysis shows no serious safety concerns,” it said.

It also said it had officially registered the vaccine, without elaborating, and that 31,000 volunteers across 125 nationalities participated in the UAE trial.

https://www.reuters.com/article/health-coronavirus-emirates/update-1-uae-says-sinopharm-vaccine-has-86-efficacy-against-covid-19-idUSL1N2IP09V
09/12/2020 3:20 PM
NPRA1985 United Arab Emirates Claims China’s Sinopharm Vaccine Is 100% Effective At Preventing Moderate And Severe Covid-19

TOPLINE The experimental vaccine developed by China National Pharmaceutical Group, also known as Sinopharm, is 86% effective at preventing Covid-19 infection and 100% effective at preventing severe and moderate disease, health officials from the United Arab Emirates announced Wednesday, although with scarce detail provided about the trial.

The UAE health ministry cited an interim analysis of a late-stage clinical trial involving 31,000 volunteers as the source of its information, though neither they nor Sinopharm provided any data from the trial to validate the claims such as how many participants were infected or how many actually received the vaccine.

The ministry said “no serious safety concerns” were observed, though, again, no information on side effects was provided.

The ministry said the announcement is a “significant vote of confidence by the UAE’s health authorities in the safety and efficacy of this vaccine.”

The ministry added that it had officially registered the vaccine at the request of the manufacturer, which it says could eventually lead to the shot’s widespread authorization.

https://www.forbes.com/sites/roberthart/2020/12/09/united-arab-emirates-claims-chinas-sinopharm-vaccine-is-100-effective-at-preventing-moderate-and-severe-covid-19/?sh=2a60fb42595c
09/12/2020 10:25 PM
NPRA1985 Hong Kong’s Ming Pao daily said in its editorial that there were grounds to believe that the UAE must have been stringent with the review and registration of the Chinese vaccine, given the country’s record of being transparent in its anti-virus policymaking and mass testing.

“The UAE also maintains sound ties with the West so sourcing vaccines from the United States or elsewhere should not be a grave challenge. If the Chinese vaccine is not safe or effective, there is no reason for the UAE to endorse Beijing’s vaccine propaganda and risk its own image and the health of its own people.

“Thus the UAE’s approval and its top leader’s injection of the SinoPharm vaccine have come as a much-needed vote of confidence that will help convince more countries. Diversified supply of vaccines, with viable alternatives from China, is key to ensuring fair and equitable access by poor countries,” said the op-ed.

SinoPharm revealed that senior officials in Egypt and Bahrain also took part in trials held there.

https://asiatimes.com/2020/12/uae-gives-chinese-vaccines-a-shot-in-the-arm/
10/12/2020 11:56 PM
NPRA1985 Pfizer Vaccine Cleared in U.S., a Landmark in Covid-19 Fight

Pfizer Inc. gained emergency U.S. authorization for its Covid-19 vaccine on Friday, completing an unprecedented scientific sprint that could eventually help bring an end to a pandemic that has killed nearly 300,000 Americans

https://www.bloomberg.com/news/articles/2020-12-12/pfizer-covid-vaccine-wins-u-s-fda-emergency-use-authorization
12/12/2020 5:36 PM
NPRA1985 Bahrain Approves China’s Sinopharm Covid-19 Vaccine

Bahrain approved the registration of the Sinopharm Group Co Ltd. vaccine against the coronavirus, about a week after the United Arab Emirates registered the Chinese-made vaccine.

“Results from Phase III clinical trials showed an 86% efficacy rate, a 99% seroconversion rate of neutralizing antibody and 100% effectiveness in preventing moderate and severe cases of Covid-19,” the National Health Regulatory Authority said in a statement Sunday.

Bahrain has participated in phase III clinical trials, in which more than 7,700 volunteers signed up. Bahrain had previously authorized the emergency use of the vaccine, which was provided to frontline workers in contact with coronavirus patients.

The UAE registered the Sinopharm vaccine after finding it had a 86% efficacy rate, paving the way for a full public use and allowing for a re-opening of the Gulf nation’s economy.

Egypt plans to start the process of inoculation against the coronavirus after receiving the first shipments of Sinopharm vaccine.

https://www.bloomberg.com/news/articles/2020-12-13/bahrain-approves-china-s-sinopharm-covid-19-vaccine

https://abcnews.go.com/Health/wireStory/bahrain-approves-chinese-covid-19-vaccine-74699175
13/12/2020 5:31 PM
NPRA1985 Govt to increase Covid-19 vaccine purchase to cover 60%-70% of M'sians — PM

The government has plans to increase its purchase of the Covid-19 vaccine to cover the immunisation needs of about 60%-70% of Malaysians compared with 30% currently.

Prime Minister Tan Sri Muhyiddin Yassin said this was because some nations had purchased doses exceeding their population.

“As for Malaysia, we have already got 30%. I have instructed Health Minister Datuk Seri Dr Adham Baba along with [Science, Technology and Innovation Minister] Khairy Jamaluddin Abu Bakar to negotiate and increase it from 30% to 60% or 70%.

https://www.theedgemarkets.com/article/govt-mulls-increasing-covid19-vaccine-purchase-30-6070-meet-msians-immunisation-needs-%E2%80%94-pm
13/12/2020 6:14 PM
RainT consecutive 2 qtr profit & margin drop
19/02/2021 6:11 PM
RainT KOTRA have touch any vaccine biz?

think is no relate at all
19/02/2021 6:12 PM
MF0001 KOTRA COME TO PAPA

DROP TO PAPA

1.850 PLZZZZZZZZZZZZZZZZZZZZZZZZZZZZZ

:DDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD
25/03/2021 3:52 PM
risktoreward 2.36 beli
19/07/2021 12:11 PM
risktoreward have to sacrifice this baby, let go at 2.30
23/07/2021 4:22 PM
ValueMe Yummy
24/08/2021 4:57 PM
wallstreetrookie Looks like another gapper/limit up stock
01/09/2021 9:14 AM
ValueMe Today traders buy tomorrow they sell.Only happens in KLSE.Just shows the level of confidence among investors and traders :D
01/09/2021 11:00 AM
holihom what happen? 3.13 now
01/09/2021 11:40 AM
wazhab Good profit
01/09/2021 12:05 PM
wallstreetrookie Under the radar pharmaceutical company. Similar to YSPSAH, Apex Healthcare
01/09/2021 12:10 PM
wallstreetrookie No price target because the market cap is too small
01/09/2021 12:10 PM
wallstreetrookie This is the best company for M&A if this company is listed in other markets lol
01/09/2021 12:13 PM
wallstreetrookie Tomorrow another round of limit-up for sure. Such a hidden gem
01/09/2021 12:13 PM
ValueMe Sell off before con yy starts promoting this stock. 30 percent in 1 week.Yummy Yummy.
01/09/2021 12:18 PM
troy88 Well done. Another round of big gains tomorrow..
01/09/2021 12:18 PM
yang88 Congratulations to those long term investors..
01/09/2021 12:47 PM
Primeinvestor superb results, no wonder limit up, how can it achieved such a good profit
01/09/2021 4:17 PM
yang88 Yaloh, Revenue 43+m, profit 14m, profit margin 28%, incredible......how do they achieve??
01/09/2021 6:22 PM
KingEdwardIIX nowsday..ppl pump n dump...carefull..
01/09/2021 7:41 PM
sadforvivo KingEdwardIIX agree with you. if want to trade, better set CL level.
03/09/2021 7:20 PM
clouud1234 Post removed. Why?
08/09/2021 9:53 AM
wallstreetrookie Add more
30/09/2021 12:45 PM
wallstreetrookie Kotra Industries Maintain Overweight
07/10/2021 8:18 AM
wallstreetrookie Buy the dip
17/10/2021 5:22 PM
wallstreetrookie Stocks to watch in Q1 2022
17/10/2021 5:22 PM
26/10/2021 4:20 PM
treasurehunt One day show?
30/11/2021 4:15 PM
Keeheong1960 A good share move up slowly.
08/12/2021 10:13 AM
treasurehunt No more story? Nova performance is good as well.
09/12/2021 5:47 PM
ipohwhitecoffee Good QR growth. Must DCA in portfolio. Despite low volume lol
13/12/2021 11:37 AM
wallstreetrookie @ipohwhitecoffee
It is the only self-sustainable pharmaceutical company on Bursa. Very low risk compared to MGRC lolllll haha
13/12/2021 11:41 AM
wallstreetrookie MGRC is high-risk bio tech firm. Kotra is boomer old fashioned Pharma bio tech company
13/12/2021 11:41 AM
wallstreetrookie 2021 Q4 Revenue Breakdown

70.5% Malaysia
29.5% Other Countries APAC

Excess Cash: 68.7 M
P/FCF - 6.96
EV/EBITDA - 5.37
27/12/2021 12:01 PM
wallstreetrookie Biotech companies always outperform during economic recession
27/12/2021 12:02 PM
treasurehunt Kotra liquidity is rather low. Gross Margin has surged more than double digit for the last 2 quarters. It's quite similar with Nova. But Nova fetchs at much higher multiple PER.
27/12/2021 12:11 PM
wallstreetrookie Both are very different industries. Do more research
27/12/2021 1:10 PM
treasurehunt Kotra has started its capex in last FY. Majority of the capex will be incurred in FY2022.

AGM minutes 2020
For FY2021, the Group’s capital expenditure to upgrade manufacturing
equipment, including cost of expansion of warehouse, is RM57 million. A
major portion of the cost may be incurred mainly in FY2022.
27/12/2021 1:15 PM
wallstreetrookie Those are forward-looking statement that no one cares
27/12/2021 3:37 PM
wallstreetrookie KTRI MK FA <GO>

Easy
27/12/2021 3:38 PM
ipohwhitecoffee Boring, but solid. Not much noises also
31/12/2021 4:43 PM
tales029 break out already
13/01/2022 9:08 PM
treasurehunt Cool!
14/01/2022 4:41 PM


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Perform Technical & Fundamental Analysis on Stocks
MQ Affiliate
Earn rewards by referring your friends
 
 

523  265  549  910 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 G3 0.080.00 
 CORAZA 0.645+0.365 
 MMAG 0.080.00 
 DNEX 0.965+0.055 
 AGES 0.025-0.01 
 EASTLND-OR 0.005-0.005 
 SMTRACK 0.22-0.005 
 SAPNRG 0.050.00 
 ARBB-OR 0.005-0.005 
 HSI-HML 0.06-0.135 
PARTNERS & BROKERS